Development and pre-clinical characterization of two therapeutic equine formulations towards SARS-CoV-2 proteins for the potential treatment of COVID-19
G. Leon, M. Herrera, M. Vargas, M. Arguedas, A. Sanchez, A. Segura, A. Gomez, G. Solano, E. Corrales-Aguilar, K. Risner, A. Narayanan, C. Bailey, M. Villalta, A. Hernandez, A. Sanchez, , A. Alape
This paper develops and pre-clinically evaluates two equine-derived anti-SARS-CoV-2 polyclonal formulations for potential COVID-19 treatment, showing high neutralizing capacity against SARS-CoV-2 infection.
bioRxiv · Oct 17, 2020 · PreprintMicrobiology